A method to increase the expression and secretion of ferulic acid esterase
By heterologously expressing Lactobacillus amyloliquefaciens esterase in Escherichia coli and optimizing the T7 promoter and 5'UTR sequence, the problem of insufficient production of esterase was solved, and the expression level was significantly improved to meet the needs of industrial applications.
Patent Information
- Application Number
- CN202310678048.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-07
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2043-06-07
AI Technical Summary
The production of ferulic acid esterase in the current technology is insufficient, which limits its application potential in the food and feed industries.
Heterologous expression of the ferulic acid esterase FaeLam derived from Lactobacillus amyloliquefaciens in Escherichia coli was achieved by cascading the T7 promoter and optimizing the 5'UTR sequence to increase its expression and secretion levels.
It significantly increased the extracellular protein production of ferulic acid esterase, reaching 3901.19 U/L and 3752.24 U/L, which were 36.46% and 31.25% higher than the control group, respectively, thus improving production efficiency.
Smart Images

Figure CN116837012B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to a method for increasing the expression and secretion of ferulic acid esterase, belonging to the field of bioenzyme technology. Background Technology
[0002] Ferulicacid esterases (EC3.1.1.73, FAE), also known as cinnamic acid esterases, are carboxylesterases. Specifically, they are enzymes that hydrolyze the ester bonds in methyl ferulic acid, oligosaccharide ferulic acid esters, and polysaccharide ferulic acid esters, releasing ferulic acid. Ferulic acid plays a crucial role in plant cell wall structure. It forms crosslinks between lignin and lignin, lignin and hemicellulose, and hemicellulose and hemicellulose, thus creating a skeletal structure that makes the entire cell wall rigid. Ferulicacid esterases can break the crosslinks between polysaccharides and between polysaccharides and lignin in the cell wall, facilitating the degradation of polysaccharides and the release of lignin from cell wall materials. Therefore, they have broad application prospects in the food, feed, and paper industries. In the food industry, ferulic acid esterase can be used to break the cross-linking between ferulic acid and polysaccharides in cell wall materials such as bran and straw, efficiently degrading polysaccharides and obtaining trans-ferulic acid. The hydrolysis products of ferulic acid esterase, which works in conjunction with arabinoxylanase, are oligosaccharides (mainly xylooligosaccharides) and ferulic acid, both important functional food bases. Pentoses can be used for alcoholic fermentation and the production of xylitol. In the feed industry, treating plant-based raw materials with ferulic acid esterase can release ferulic acid from the structure of plant cell walls, thereby disrupting the cell wall's skeletal structure. This partially breaks down the bonds between lignin, hemicellulose, and cellulose, making the structure looser than before treatment. Looser raw materials are more easily digested and absorbed by livestock, improving feed utilization efficiency.
[0003] The diverse biotechnological functions of ferulic acid esterase make it highly promising for industrial production. However, current research primarily focuses on the isolation and purification of ferulic acid esterase from various microorganisms. For instance, Chinese patent document CN110066757A (application number 201910312493.5) discloses a strain of *Pseudomonas* that produces ferulic acid esterase. This strain secretes ferulic acid esterase, and under wheat bran induction, the activity of its crude fermentation enzyme solution is 116 U / L. Furthermore, the yield of ferulic acid produced by fermenting wheat bran as a substrate can reach 59.51 ± 0.6 mg / L. Therefore, developing other methods and approaches to increase the yield of ferulic acid esterase remains essential. Summary of the Invention
[0004] To address the shortcomings of existing technologies, this invention provides a method for increasing the expression and secretion of ferulic acid esterase. This invention utilizes *Escherichia coli*, a classic prokaryotic gene expression host, to heterologously express the ferulic acid esterase *FaeLam* derived from *Lactobacillus amyloliquephala*. Previous studies have shown that when heterologously expressed in *E. coli*, *FaeLam* can be stably expressed and secreted extracellularly. Building upon this, methods such as *E. coli* codon preference optimization, cascaded T7 promoter, and 5'UTR replacement are used to significantly increase the expression and extracellular secretion of ferulic acid esterase, thereby providing a new production strain and method for ferulic acid esterase production.
[0005] The technical solution of the present invention is as follows:
[0006] One method to increase the expression and secretion of ferulic acid esterase is to cascade 2 to 4 T7 promoters at the start of the ferulic acid esterase encoding gene.
[0007] According to a preferred embodiment of the present invention, four T7 promoters are cascaded at the start of the ferulic acid esterase encoding gene.
[0008] According to a preferred embodiment of the present invention, the ferulic acid esterase is a ferulic acid esterase derived from Lactobacillus amyloliquefaciens CGMCC No. 11056, the amino acid sequence of which is shown in SEQ ID NO. 1.
[0009] According to a preferred embodiment of the present invention, the nucleotide sequence of the ferulic acid esterase encoding gene is shown in SEQ ID NO.3.
[0010] According to a preferred embodiment of the present invention, the expression host of the ferulic acid esterase is Escherichia coli.
[0011] A preferred embodiment of the present invention, a specific method for increasing the expression and secretion of ferulic acid esterase, includes the following steps:
[0012] (1) Using the plasmid pET22b-Opt-Fae containing the ferulic acid esterase encoding gene as a template, reverse PCR was used to amplify the vector fragment T7-Re, which does not contain the T7 promoter sequence. Then, PCR was used to amplify the fragment T7×2-4, which contains the homologous arm sequence of the ferulic acid esterase encoding gene and cascades 2-4 T7 promoters. The T7-Re fragment was ligated with the T7×2-4 fragment to construct the recombinant plasmid pET22b-T7×2-4-Opt-Fae, which cascades 2-4 T7 promoters at the start end of the ferulic acid esterase encoding gene. The amino acid sequence of the ferulic acid esterase is shown in SEQ ID NO.1, and the nucleotide sequence is shown in SEQ ID NO.3.
[0013] (2) Transform the recombinant plasmid pET22b-T7×2~4-Opt-Fae constructed in step (1) into E. coli BL21 to construct a recombinant strain;
[0014] (3) The recombinant strain constructed in step (2) is induced to express.
[0015] A method for increasing the expression and secretion of ferulic acid esterase involves replacing the original 5'UTR sequence upstream of the start codon of the ferulic acid esterase encoding gene with UTR-A, UTR-B, or UTR-C, wherein the nucleotide sequence of the original 5'UTR sequence is shown in SEQ ID NO.4, the nucleotide sequence of UTR-A is shown in SEQ ID NO.5, the nucleotide sequence of UTR-B is shown in SEQ ID NO.6, and the nucleotide sequence of UTR-C is shown in SEQ ID NO.7.
[0016] According to a preferred embodiment of the present invention, the ferulic acid esterase is a ferulic acid esterase derived from Lactobacillus amyloliquefaciens CGMCC No. 11056, the amino acid sequence of which is shown in SEQ ID NO. 1.
[0017] According to a preferred embodiment of the present invention, the nucleotide sequence of the ferulic acid esterase encoding gene is shown in SEQ ID NO.3.
[0018] According to a preferred embodiment of the present invention, the expression host of the ferulic acid esterase is Escherichia coli.
[0019] A preferred embodiment of the present invention, a specific method for increasing the expression and secretion of ferulic acid esterase, includes the following steps:
[0020] (a) Using the plasmid pET22b-Opt-Fae containing the ferulic acid esterase encoding gene as a template, reverse PCR was performed to amplify the UTR-Re fragment, which does not contain the original 5'UTR sequence and the ferulic acid esterase encoding gene sequence. Then, the UTR-Opt-Fae fragment containing the UTR-A, UTR-B, or UTR-C sequence and the ferulic acid esterase encoding gene sequence was obtained by PCR amplification. The UTR-Re fragment was ligated to the UTR-Opt-Fae fragment to construct a recombinant plasmid in which the original 5'UTR sequence was replaced with UTR-A, UTR-B, or UTR-C. The amino acid sequence of the ferulic acid esterase is shown in SEQ ID NO.1, and the nucleotide sequence is shown in SEQ ID NO.3.
[0021] (b) Transform the recombinant plasmid constructed in step (a) into E. coli BL21 to construct a recombinant strain;
[0022] (c) Induce expression of the recombinant strain constructed in step (b).
[0023] According to a preferred embodiment of the present invention, when obtaining the UTR-Opt-Fae fragment containing the UTR-A, UTR-B, or UTR-C sequence and the ferulic acid esterase encoding gene sequence by PCR amplification in step (a), the upstream primer sequence used contains the UTR-A, UTR-B, or UTR-C sequence fragment.
[0024] Beneficial effects:
[0025] 1. Promoters are among the most important and fundamental tools for achieving various biological goals. They are the first switch for gene expression, directly determining intracellular mRNA concentration during the transcription stage. The pET expression system with a T7 promoter is currently the most widely used heterologous expression system in *E. coli*. Due to the high activity of the T7 promoter, recombinant proteins can accumulate up to 50% of the total cellular protein, and T7 RNA polymerase exhibits high selectivity for its own promoter. Therefore, increasing the number of cascaded T7 promoters and improving the binding efficiency of T7 RNA polymerase can enhance transcription and translation expression capabilities, holding great research potential in optimizing the complex metabolic network of *E. coli* and producing valuable products. This invention, by cascading four T7 promoters, achieved an extracellular protein yield of 3901.19 U / L for ferulic acid esterase, a 36.46% increase compared to the recombinant strain *E. coli* BL21 / pET22b-Opt-Fae.
[0026] 2. The 5' UTR (5' uncoding region) upstream of the start codon is also closely related to translation initiation and protein expression. The structural features of the 5' UTR play a crucial role in controlling translation efficiency, as protein expression is initiated by the binding of the ribosome to the Shine-Dalgarno (SD) sequence in the 5' UTR. The distance between the SD sequence and the start codon, as well as the nucleotide sequence itself, significantly affect translation efficiency and protein expression. This invention, by replacing the 5' UTR, achieved a maximum extracellular protein yield of 3752.24 U / L for ferulic acid esterase, representing a 31.25% increase compared to E. coli BL21 / pET22b-Opt-Fae. Attached Figure Description
[0027] Figure 1 The bar chart shows the relative enzyme activity of ferulic acid esterase in intracellular and extracellular protein samples of recombinant strains before and after codon optimization; in the figure, FaeLam represents recombinant strain E.coli BL21 / pET22b-FaeLam, and Opt-Fae represents recombinant strain E.coli BL21 / pET22b-Opt-Fae.
[0028] Figure 2SDS-PAGE electrophoresis images of protein samples from recombinant strains before and after codon optimization; in the image, lane 1: whole-cell protein sample of E. coli BL21 / pET22b-FaeLam; lane 2: intracellular protein sample of E. coli BL21 / pET22b-FaeLam; lane 3: extracellular protein sample of E. coli BL21 / pET22b-FaeLam; lane 4: whole-cell protein sample of E. coli BL21 / pET22b-Opt-Fae; lane 5: intracellular protein sample of E. coli BL21 / pET22b-Opt-Fae; lane 6: extracellular protein sample of E. coli BL21 / pET22b-Opt-Fae.
[0029] Figure 3 This is a bar chart showing the relative enzyme activity of ferulic acid esterase in extracellular protein samples of recombinant strains following the T7 promoter cascade. In the figure, T7×1 represents the recombinant strain E. coli BL21 / pET22b-Opt-Fae; T7×2 represents the recombinant strain E. coli BL21 / pET22b-T7×2-Opt-Fae; T7×3 represents the recombinant strain E. coli BL21 / pET22b-T7×3-Opt-Fae; T7×4 represents the recombinant strain E. coli BL21 / pET22b-T7×4-Opt-Fae; and T7×5 represents the recombinant strain E. coli BL21 / pET22b-T7×5-Opt-Fae.
[0030] Figure 4 SDS-PAGE electrophoresis images of extracellular protein samples from recombinant strains following the T7 promoter cascade; in the image, lane 1: E. coli BL21 / pET22b-Opt-Fae; lane 2: E. coli BL21 / pET22b-T7×2-Opt-Fae; lane 3: E. coli BL21 / pET22b-T7×3-Opt-Fae; lane 4: E. coli BL21 / pET22b-T7×4-Opt-Fae; lane 5: E. coli BL21 / pET22b-T7×5-Opt-Fae.
[0031] Figure 5This is a bar chart showing the relative enzyme activity of ferulic acid esterase in extracellular protein samples of recombinant strains under different 5' UTRs. In the figure, Opt-Fae represents recombinant strain E. coli BL21 / pET22b-Opt-Fae; A-UTR represents recombinant strain E. coli BL21 / pET22b-UTRA-Opt-Fae; B-UTR represents recombinant strain E. coli BL21 / pET22b-UTRB-Opt-Fae; C-UTR represents recombinant strain E. coli BL21 / pET22b-UTRC-Opt-Fae; D-UTR represents recombinant strain E. coli BL21 / pET22b-UTRD-Opt-Fae; and E-UTR represents recombinant strain E. coli BL21 / pET22b-UTRE-Opt-Fae.
[0032] Figure 6 SDS-PAGE electrophoresis images of extracellular protein samples from recombinant strains at different 5' UTRs; in the image, lane 1: E. coli BL21 / pET22b-Opt-Fae; lane 2: E. coli BL21 / pET22b-UTRA-Opt-Fae; lane 3: E. coli BL21 / pET22b-UTRB-Opt-Fae; lane 4: E. coli BL21 / pET22b-UTRC-Opt-Fae; lane 5: E. coli BL21 / pET22b-UTRD-Opt-Fae; lane 6: E. coli BL21 / pET22b-UTRE-Opt-Fae. Detailed Implementation
[0033] The technical solution of the present invention will be further described below with reference to the embodiments, but the scope of protection of the present invention is not limited thereto. Unless otherwise specified, the materials and reagents involved in the embodiments are all commercially available products.
[0034] The example uses the ferulic acid esterase FaeLam derived from Lactobacillus amyloliquefaciens CGMCC No.11056 as the research object. The amino acid sequence of the ferulic acid esterase FaeLam is shown in SEQ ID NO.1, and the nucleotide sequence of its encoding gene is shown in SEQ ID NO.2. The nucleotide sequence after codon optimization by Escherichia coli is shown in SEQ ID NO.3.
[0035] Example 1: Codon optimization of the ferulic acid esterase gene sequence
[0036] 1. Construction of recombinant plasmids from the original ferulic acid esterase gene sequence
[0037] The genome of *Lactobacillus amyloliquefaciens* CGMCC No. 11056 was extracted using a genome extraction kit. The ferulic acid esterase gene sequence FaeLam from the *Lactobacillus amyloliquefaciens* CGMCC No. 11056 genome was obtained by PCR amplification using primers Fae-F and Fae-R. The primer sequences are as follows:
[0038] Fae-F:5'-TAAGAAGGAGATATA CATATG TCCCGCATTACAATT-3', underscore is NdeI
[0039] Enzyme cleavage site,
[0040] Fae-R: 5'-CTCAGTGGTGGTGGTGGTGGTG CTCGAG GAATAATGGTTTTAAAAAT-3', the underlined part is the XhoI restriction site.
[0041] The PCR amplification system is shown in Table 1:
[0042] Table 1. PCR amplification system
[0043]
[0044] The PCR amplification procedure is shown in Table 2:
[0045] Table 2. PCR amplification program
[0046]
[0047] After purification using a product purification kit, the PCR amplification product yielded the FaeLam fragment, containing NdeI and XhoI restriction sites, of the ferulic acid esterase gene sequence. Using the ClonExpress II one-step cloning kit, the FaeLam fragment was ligated into the pET22b vector fragment, which had undergone double digestion with restriction endonucleases NdeI and XhoI. The double digestion system for the restriction endonucleases is shown in Table 3.
[0048] Table 3. Double enzyme digestion system
[0049]
[0050] The one-step cloning system is shown in Table 4:
[0051] Table 4 One-step cloning system
[0052]
[0053] The ligation product was transformed into E. coli competent cells using a heat shock method. The specific procedure was as follows: E. coli competent cells were removed from a -80℃ freezer and thawed on ice; 10 μL of ligation product was added, and the mixture was gently tapped into a 1.5 mL EP tube for mixing. The tubes were then incubated in an ice-water bath for 30 min; the competent cells were then heat-shocked at 42℃ for 90 s, immediately followed by an ice-water bath for 2 min, and then 900 μL of fresh LB medium was added. The cells were then incubated at 37℃ with shaking for 1 h; the thawing solution was centrifuged at 6000 rpm for 3 min, and a portion of the supernatant was aspirated. The thawing solution was then spread on LB plates containing 100 μg / mL ampicillin and incubated at 37℃ for 24 h. Transformants were picked and cultured overnight at 37℃ in liquid LB medium containing 100 μg / mL ampicillin. The plasmid was extracted using a plasmid extraction kit. Plasmid PCR was performed using primers Fae-F and Fae-R to verify the plasmid, and the recombinant plasmid was obtained and named pET22b-FaeLam.
[0054] 2. Construction of recombinant plasmids for optimizing the ferulic acid esterase gene sequence
[0055] The ferulic acid esterase gene sequence FaeLam was optimized for codon bias in *E. coli*, and the optimized gene sequence Opt-Fae was synthesized by Nanjing Paisennong Gene Co., Ltd. The Opt-Fae gene sequence was amplified by PCR using primers Opt-Fae-F and Opt-Fae-R. The PCR amplification system is shown in Table 1, the PCR amplification program is shown in Table 2, and the primer sequences are as follows:
[0056] Opt-Fae-F: 5'-TAAGAAGGAGATATA CATATG AGCCGTATTACCATTGAAC-3', the underlined part is the NdeI restriction site.
[0057] Opt-Fae-R: 5'-CAGTGGTGGTGGTGGTGGTG CTCGAG AAACAGCGGTTTCAGAAAC-3', the underlined part is the XhoI restriction site.
[0058] The amplified product was purified using a product purification kit to obtain the optimized ferulic acid esterase gene sequence Opt-Fae fragment containing restriction endonuclease sites NdeI and XhoI. Using the ClonExpress II one-step cloning kit, the Opt-Fae fragment was ligated into the pET22b vector fragment, which had been double-digested with NdeI and XhoI. The ligation product was transformed into E. coli competent cells using a heat shock method. Transformants were screened, and plasmids were extracted using a plasmid extraction kit. Plasmid PCR verification was performed using primers Opt-Fae-F and Opt-Fae-R to obtain the recombinant plasmid, which was named pET22b-Opt-Fae.
[0059] 3. Transformation and expression of recombinant plasmids
[0060] The recombinant plasmids pET22b-FaeLam and pET22b-Opt-Fae constructed above were transformed into E. coli BL21 by heat shock. The plasmids were then plated onto LB agar plates containing 100 μg / mL ampicillin and incubated overnight at 37°C. Colonies were picked and inoculated onto LB liquid medium containing 100 μg / mL ampicillin and cultured overnight at 37°C with shaking to obtain recombinant strains E. coli BL21 / pET22b-FaeLam and E. coli BL21 / pET22b-Opt-Fae.
[0061] The recombinant strain was transferred at a ratio of 1% (v / v) to LB liquid medium containing 100 μg / mL ampicillin and cultured until OD500. 600 After reaching a final concentration of 0.5 mM, IPTG was added, and the mixture was induced at 37°C for 36 h. After induction, the bacterial culture was centrifuged at 12000 rpm for 5 min, and the supernatant was filtered through a 0.22 μm filter. 5×SDS-PAGE loading buffer was added at a 4:1 volume ratio to obtain extracellular protein samples. The centrifuged bacterial cells were collected and resuspended in buffer A (8 g sodium chloride, 0.2 g potassium chloride, 1.44 g disodium hydrogen phosphate, and 0.27 g potassium dihydrogen phosphate dissolved in 1000 mL ddH2O, with pH adjusted to 7.0 using hydrochloric acid and sodium hydroxide). The cells were then sonicated using an ultrasonic cell disruptor. The cell lysate was added at a 4:1 volume ratio to obtain whole-cell protein samples. The cell lysate was centrifuged at 12000 rpm for 5 min, and the supernatant was added at a 4:1 volume ratio to obtain intracellular protein samples. The whole-cell, intracellular, and extracellular protein samples prepared above were analyzed by 12% SDS-PAGE, and the enzyme activity of ferulic acid esterase in the intracellular and extracellular protein samples was determined by UV method.
[0062] The specific procedure for determining the activity of ferulic acid esterase in protein samples using the UV method is as follows: First, determine the ferulic acid-p-nitrophenol (4-NP) standard curve. Add different volumes (0, 20, 40, 60, 80, 100 μL) of DSMO solution containing 10 mM 4-NP to 0.9 mL of buffer A containing 2.5% (v / v) Triton X-100, then add DMSO to make up to 1 mL. Quickly incubate the reaction solution at 37℃ for 10 min, and measure the absorbance at 405 nm using a microplate reader to plot the standard curve. Then, perform the assay on the protein sample. 100 μL of 10 mM ferulic acid p-nitrophenol ester (4-NPF) DSMO solution, 800 μL of buffer A containing 2.5% (v / v) Triton X-100, and 100 μL of protein sample were mixed and immediately incubated at 37°C for 10 min. The absorbance at 405 nm was measured using a microplate reader, and the enzyme activity was calculated by substituting the values into the standard curve. Each sample was measured three times. Three parallel experiments were set up, and the error bar represents the standard deviation of three replicate experiments.
[0063] The results of the ferulic acid esterase activity assay in intracellular and extracellular protein samples are as follows: Figure 1 As shown, the SDS-PAGE results of whole-cell, intracellular, and extracellular protein samples are as follows: Figure 2 As shown in the figure, analysis revealed that after codon preference optimization in *E. coli*, the extracellular secretion of ferulic acid esterase *FaeLam* was significantly increased, by 41.97% compared to *E. coli* BL21 / pET22b-FaeLam, with an extracellular enzyme yield reaching 2858.85 U / L. Based on this finding, the recombinant strain *E. coli* BL21 / pET22b-Opt-Fae was used as the starting strain for further optimization of ferulic acid esterase yield.
[0064] Example 2: Ferula esterase gene sequence cascaded with T7 promoter
[0065] Using plasmid pET22b-Opt-Fae as a template, the vector fragment T7-Re, which does not contain the T7 promoter sequence, was amplified by reverse PCR using primers T7-Re-F and T7-Re-R. The fragment T7×2, containing homologous arms of the ferulic acid esterase gene sequence, was amplified using primers OF-T7×2-F and OF-T7-R. After the PCR program, the PCR products were subjected to DNA gel electrophoresis, and the target band was cut and purified. The purified T7-Re and T7×2 fragments were self-ligated using a one-step cloning kit. The ligation product was transformed into E. coli competent cells, and plasmid PCR verification was performed using universal primers T7-F and T7-R for the pET vector, yielding the recombinant plasmid pET22b-T7×2-Opt-Fae containing two cascaded T7 promoters. Using the same method, plasmids pET22b-T7×3-Opt-Fae, pET22b-T7×4-Opt-Fae, and pET22b-T7×5-Opt-Fae were obtained. The primer sequences used are shown in the table below:
[0066] Table 5 Primer sequences
[0067]
[0068] The recombinant plasmids pET22b-T7×2-Opt-Fae, pET22b-T7×3-Opt-Fae, pET22b-T7×4-Opt-Fae, and pET22b-T7×5-Opt-Fae constructed above were transformed into E. coli BL21 by heat shock, resulting in recombinant strains E. coli BL21 / pET22b-T7×2-Opt-Fae, E. coli BL21 / pET22b-T7×3-Opt-Fae, E. coli BL21 / pET22b-T7×4-Opt-Fae, and E. coli BL21 / pET22b-T7×5-Opt-Fae. The above recombinant strain was transferred to LB liquid medium containing 100 μg / mL ampicillin at a ratio of 1% (v / v) with E. coli BL21 / pET22b-Opt-Fae (i.e., E. coli BL21 / pET22b-T7×1-Opt-Fae) and cultured until OD500. 600 After reaching a final concentration of 0.5 mM, IPTG was added, and the mixture was induced at 37°C for 24 h to obtain extracellular protein samples. The extracellular protein samples were analyzed by 12% SDS-PAGE, and the ferulic acid esterase activity of the protein samples was determined by UV assay. Three parallel experiments were set up, with the error bar representing the standard deviation of three replicate experiments.
[0069] The results of the ferulic acid esterase activity assay of extracellular protein samples are as follows: Figure 3 As shown in Table 6, the SDS-PAGE results of the extracellular protein samples are as follows: Figure 4 As shown.
[0070] Table 6. Results of ferulic acid esterase activity assay in extracellular protein samples.
[0071] Recombinant strains T7×1 T7×2 T7×3 T7×4 T7×5 Enzyme activity (U / L) 2858.85 3420.68 3615.84 3901.19 3523.11
[0072] Note: The recombinant strains T7×1, T7×2, T7×3, T7×4, and T7×5 shown in the table represent E. coli BL21 / pET22b-T7×1-Opt-Fae, E. coli BL21 / pET22b-T7×2-Opt-Fae, E. coli BL21 / pET22b-T7×3-Opt-Fae, E. coli BL21 / pET22b-T7×4-Opt-Fae, and E. coli BL21 / pET22b-T7×5-Opt-Fae, respectively.
[0073] Analysis showed that the expression level of extracellular ferulic acid esterase FaeLam was significantly increased after cascading the T7 promoter. The expression level reached its highest when cascading four T7 promoters, but it decreased after cascading the fifth T7 promoter. Therefore, cascading four T7 promoters was determined to be the optimal method. The extracellular enzyme yield was 36.46% higher than that of the recombinant strain E.coli BL21 / pET22b-Opt-Fae, and the extracellular enzyme yield reached 3901.19 U / L.
[0074] Example 3: 5'UTR optimization of ferulic acid esterase gene sequence
[0075] High-fidelity enzymes and primers UTR-Re-F and UTR-Re-R were used for reverse PCR amplification of plasmid pET22b-Opt-Fae to obtain the UTR-Re fragment that did not contain the original 5' UTR sequence and the ferulic acid esterase gene sequence Opt-Fae. The 5' UTR-Opt-Fae fragments containing different 5' UTR sequences and the ferulic acid esterase gene sequence Opt-Fae were amplified using upstream primers UTR-AF, UTR-BF, UTR-CF, UTR-DF, and UTR-EF, respectively, and downstream primer Opt-Fae-R. The primer sequences are shown in Table 7.
[0076] Table 7 Primer sequences
[0077]
[0078] Different 5'UTR sequences are shown in Table 8:
[0079] Table 8 5'UTR Sequences
[0080]
[0081] After the PCR procedure, the PCR products were subjected to DNA gel electrophoresis, and the target band was cut and recovered from the gel. The recovered 5'UTR-Opt-Fae fragment and UTR-Re fragment were ligated using the ClonExpress II one-step cloning kit via homologous recombination. The ligation product was transformed into E. coli competent cells, and plasmid PCR verification was performed using universal primers T7-F and T7-R for the pET series vectors, yielding plasmids pET22b-UTRA-Opt-Fae, pET22b-UTRB-Opt-Fae, pET22b-UTRC-Opt-Fae, pET22b-UTRD-Opt-Fae, and pET22b-UTRE-Opt-Fae.
[0082] Five plasmids containing different 5'UTR sequences were constructed and transformed into E. coli BL21 competent cells using a heat shock method, yielding recombinant strains E. coli BL21 / pET22b-UTRA-Opt-Fae, E. coli BL21 / pET22b-UTRB-Opt-Fae, E. coli BL21 / pET22b-UTRC-Opt-Fae, E. coli BL21 / pET22b-UTRD-Opt-Fae, and E. coli BL21 / pET22b-UTRE-Opt-Fae. These recombinant strains and E. coli BL21 / pET22b-Opt-Fae were then transferred at a 1% (v / v) ratio to LB broth containing 100 μg / mL ampicillin and cultured until OD500. 600 After reaching a final concentration of 0.5 mM, IPTG was added, and the mixture was induced at 37°C for 24 h to obtain extracellular protein samples. The extracellular protein samples were analyzed by 12% SDS-PAGE, and the ferulic acid esterase activity of the protein samples was determined by UV assay. Three parallel experiments were set up, with the error bar representing the standard deviation of three replicate experiments.
[0083] Results of ferulic acid esterase activity assay in extracellular protein samples as follows Figure 5 As shown in Table 9, the SDS-PAGE results of the extracellular protein samples are as follows: Figure 6 As shown.
[0084] Table 9 Results of ferulic acid esterase activity assay in extracellular protein samples
[0085] Recombinant strains Opt-Fae UTR-A UTR-B UTR-C UTR-D UTR-E Enzyme activity (U / L) 2858.85 3752.24 3261.51 3570.53 1519.88 1283.51
[0086] Note: The recombinant strains Opt-Fae, UTR-A, UTR-B, UTR-C, UTR-D, and UTR-E shown in the table represent E. coli BL21 / pET22b-Opt-Fae, E. coli BL21 / pET22b-UTRA-Opt-Fae, E. coli BL21 / pET22b-UTRB-Opt-Fae, E. coli BL21 / pET22b-UTRC-Opt-Fae, E. coli BL21 / pET22b-UTRD-Opt-Fae, and E. coli BL21 / pET22b-UTRE-Opt-Fae, respectively.
[0087] Analysis showed that replacing the original 5'UTR with UTR-A, UTR-B, and UTR-C significantly increased the extracellular expression of ferulic acid esterase FaeLam. However, replacing with UTR-D and UTR-E decreased the extracellular expression of ferulic acid esterase FaeLam. Especially when replacing with UTR-A, the extracellular expression of ferulic acid esterase FaeLam reached its highest level, with an extracellular enzyme yield of 3752.24 U / L, which was 31.25% higher than that of E. coli BL21 / pET22b-Opt-Fae. Replacing with UTR-B and UTR-C showed increases of 14.08% and 24.89% respectively compared to E. coli BL21 / pET22b-Opt-Fae.
Claims
1. A method for increasing the expression and secretion of ferulic acid esterase, characterized in that, The original 5'UTR sequence upstream of the start codon of the ferulic acid esterase encoding gene is replaced with UTR-A, the nucleotide sequence of which is shown in SEQ ID NO.4, and the nucleotide sequence of which is shown in SEQ ID NO.5; the ferulic acid esterase is derived from Lactobacillus amyloliquefaciens CGMCC No. 11056, and its amino acid sequence is shown in SEQ ID NO.1; the expression host of the ferulic acid esterase is Escherichia coli.
2. The method as described in claim 1, characterized in that, The nucleotide sequence of the gene encoding the ferulic acid esterase is shown in SEQ ID NO.
3.
3. The method for increasing the expression and secretion of ferulic acid esterase according to claim 1, specifically includes the following steps: (a) Using plasmid pET22b- containing the gene encoding ferulic acid esterase Opt - Fae Using a template, reverse PCR amplification yielded a UTR-Re fragment that did not contain the original 5' UTR sequence and the ferulic acid esterase encoding gene sequence. Further PCR amplification yielded a UTR-Re fragment containing the UTR-A sequence and the ferulic acid esterase encoding gene sequence. Opt - Fae Fragment, combining UTR-Re fragments with UTR- Opt - Fae Fragment ligation was performed to construct a recombinant plasmid in which the original 5'UTR sequence was replaced with UTR-A; the amino acid sequence of the ferulic acid esterase is shown in SEQ ID NO.1, and the nucleotide sequence is shown in SEQ ID NO.3; (b) Transform the recombinant plasmid constructed in step (a) into E. coli In BL21, recombinant strains were constructed; (c) Induce expression of the recombinant strain constructed in step (b).
4. The method as described in claim 3, characterized in that, In step (a), UTR-A sequences containing the UTR-A sequence and the ferulic acid esterase encoding gene sequence are obtained by PCR amplification. Opt - Fae When fragmenting, the upstream primer sequence used contains a UTR-A sequence fragment.
Citation Information
Patent Citations
Pseudomonas oryzihabitans capable of secreting ferulic acid esterase and application of pseudomonas oryzihabitans
CN110066757A
A method for producing extracellular ferulic acid esterase from Escherichia coli
CN109182297A
Method for increasing expression and secretion amount of feruloyl esterase by using secretion cofactor
CN116837013A
Optimized plasmids for expression of YGHJ polypeptides
WO2025219177A1
KR20230131058A
